Helicobacter pylori-negative duodenal and pyloric ulcer: Role of NSAIDs

Digestion

Volumn 57, Issue 5, 1996, Pages 305-309

  Hyvarinen, H ^a   Salmenkyld, S ^a   Sipponene>, P ^a  

^a JORVI HOSPITAL   (Finland)

Author keywords

Duodenal ulcer; Gastritis; Helicobacter pylori; Nonsteroidal anti inflammatory drug; Pyloric ulcer; Steroidal inflammatory drug

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG USE; DUODENUM ULCER; ENDOSCOPY; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; PYLORUS; RETROSPECTIVE STUDY; STOMACH ULCER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DUODENAL ULCER; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; PYLORUS; RETROSPECTIVE STUDIES; STOMACH ULCER;

EID: 0029782549     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000201350     Document Type: Article

References (30)

1. Agrawal N: Risk factors for gastrointestinal ulcers caused by nonsteroidal anti-inflammatory drugs. J Fam Pract 1991:32:619-624.
2. Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, Bloch DA: Toward an epidemiology of gastropathy associated with nonsteroidal anti-inflammatory drug use. Gastroenterology 1989:96:647-655.
3. Soil AH, Kurata J, McGuigan JE: Ulcers, nonsteroidal anti-inflammatory drugs, and related matters. Gastroenterology 1989:96:561-568.
4. Larkai EN, Smith JL, Lidsky MD, Draham DY: Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 1987:82:1153-1158.
5. Silvoso GR, Ivey KJ, Butt JH, el at: Incidence of gastric lesions in patients with rheumatoid disease on chronic aspirin therapy. Ann Intern Med 1979:91:517-520.
6. Morris AD, Holt SD, Silvoso GR. et al: Effect of anti-inflammatory drug administration in patients with rheumatoid arthritis. An endoscopic assessment. Scand J Gastroenterol 1981: 16:131-135.
7. Laine L, Marin-Sorensen M, Weinstein WM: Nonsteroidal anti-inflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development. Am J Gastroenterol 1992:87:1398-1402.
8. Price AB: The Sydney System: Histological division. J Gastroenterol Hepatol 1991:6:209-222.
9. Graham DY, Agrawal NM, Roth S: Prevention of NSAID-induccd gastric ulcer with Misopros-taol: Mullicemer. double-blind, placebo-controlled trial. Lancet 1988;ii: 1277-1280.
10. Kim JG. Graham DY: Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. The Misoprostol study groups. Am J Gastroenterol 1994;89:203-207.
11. Farr CM: NSAlD-induced ulcers and prophylaxis. A reappraisal. J Clin Gastroenterol 1993: 17:187-188.
12. Flallas J, Lauritsen J, Dalsgard Villadsen H, Fren Gram L: Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates. Scand J Gastroenterol 1995:30:438-444.
13. Zlass AM, McHenry L Jr, Sanyal AJ: Nonsteroidal anti-inflammatorv drug-induced gastroduodenal lesions: Prophylaxis and treatment. Gastroenterologist 1993; 1:165-169.
14. Llewelyn FG, Pritchard MH: Acute gastric haemorrhage and its relationship to the use of anti-inflammatory analgesics. Ann Rheum Dis 1983:42:228-229.
15. Armstrong CP, Blower A: Non-steroidal antiinflammatory drugs and life-threatening complications or peptic ulceration. Gut 1987:28: 527-532.
16. Collier DSTJ, Pain JA: Non-steroidal antiinflammatory drugs and peptic ulcer perforation. Gut 1985;26:359-363.
17. Sommcrville K, Faulkner G, Langman MJS: Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986:i:462-464.
18. Schiller KFR, Truclovc SC, Williams DG: I le-matemesis and mclacna. with special reference to factors influencing the outcome. Br Med J 1970:ii:25.
19. Agrawal NM: Anti-inflammatories and gastroduodenal damage: Therapeutic options. Eur J Rheumatol Inflamm 1993;13:17-24.
20. Kimmey MB: NSAID. ulcers, and prostaglandins. J Rheumatol 1992;19(suppl 36):68-73.
21. Graham DY: Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy. Gastroenterology 1989:96:675-681.
22. Fenn GC: Review article: Controversies in NSAID-induccd gastroduodenal damage-Do they matter. Aliment Pharmacol Ther 1994:8: 15-26.
23. McCarthy DM: Nonsteroidal anti-inflammatory drug-induced ulcers: Management by traditional therapies. Gastroenterology 1989:96: 662-674.
24. Miller DR: Treatment of nonsteroidal antiinflammatory drug-induced gastropathy. Clin Pharm 1992; 11:690-704.
25. Taha AS, Sturrock RD, Russell RI: Mucosal erosions in long-term non-steroidal anti-inflammatory drug users: Predisposition to ulceration and relation to Helicobacter pvhri. Gut 1995;36:334-336.
26. Graham DY, Lidsky MD, Cox AM. et al: Longterm nonsteroidal anti-inflammatory drug use and Helicobacter pylori infection. Gastroenterology 1991:100:1673-1657.
27. McCarthy DM: Helicobacter pylori infection and gastroduodenal injury by non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1991;26(suppl 187):91-97.
28. Borodv TJ, George LL, Brandi S, Andrews P, Ostapowicz N, Hyland L, Devine M: Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 1991:86:1154-1157.
29. Ncnsey YM, Schubert TT, Bologna SD, Ma CK: Helicobacter pylori-negative duodenal ulcer. Am J Med 1991;91:15-18.
30. Caruso I, Bianchi Porro G: Gastroscopic evaluation of anti-inflammatory agents. Br Med J 1980;280:75-80.